Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

October 2, 2023

Novartis offloads ophthalmology assets for $2.5bn

Novartis has concluded the sale of its ‘front of eye’ ophthalmology assets to eye health company Bausch + Lomb for up to $2.5bn.

Novartis offloads ophthalmology assets for $2.5bn